Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7355 EUR 2.65% Market Closed
Market Cap: 498.9m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Net Income (Common) Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Net Income (Common)
-$13.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
6%
ProQR Therapeutics NV
NASDAQ:PRQR
Net Income (Common)
-€21.5m
CAGR 3-Years
27%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Net Income (Common)
-$239.5m
CAGR 3-Years
N/A
CAGR 5-Years
-18%
CAGR 10-Years
-19%
argenx SE
XBRU:ARGX
Net Income (Common)
-$277m
CAGR 3-Years
20%
CAGR 5-Years
-22%
CAGR 10-Years
-51%
Merus NV
NASDAQ:MRUS
Net Income (Common)
-$244.6m
CAGR 3-Years
-45%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Net Income (Common)
-$42m
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Net Income (Common)?
Net Income (Common)
-13.3m USD

Based on the financial report for Jun 30, 2024, Pharming Group NV's Net Income (Common) amounts to -13.3m USD.

What is Pharming Group NV's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%

Over the last year, the Net Income (Common) growth was 19%.

Back to Top